General Medicine and Primary Care

Guest: Darvin Scott Smith, MD

For optimal protection, the most prevalent flu strains are assessed every year and included in the vaccine. Here to talk about this process and the recent decision to exclude the B/Yamagata lineage from flu vaccines is Dr. Darvin Scott Smith, Infectious Disease and Geographic Medicine Consultant at San Mateo Medical Center in California.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Jill Foster, MD

For optimal protection, the best time for patients to receive a flu shot is between September and October, but some patients may be hesitant. In fact, flu vaccination rates have been declining since the onset of the COVID-19 pandemic according to the CDC. That’s why Dr. Charles Turck speaks with Dr. Jill Foster about how we can help ensure patients receive timely and annual flu vaccinations. Dr. Foster is the Director of the Division of Pediatric Infectious Diseases at the University of Minnesota Medical School in Minneapolis.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Christina Madison, BS, PharmD, BCACP, AAHIVP

The World Health Organization and the Vaccines and Related Biologics Products Advisory Committee recently recommended transitioning from quadrivalent to trivalent flu vaccines that exclude the B/Yamagata lineage. Explore the epidemiological data that led to this decision and counseling strategies that can help patients understand this new recommendation with Dr. Charles Turck and Dr. Christina Madison, founder and CEO of the Public Health Pharmacist.

Host: Jennifer Caudle, DO

Guest: Tamera A. Paczos, MD, FACOG, FACP

The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.

COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23

Host: Warner K. Huh, MD

Guest: Kimberly Levinson, MD, MPH

More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the potential for unnecessary colposcopies. Enduring consensus cervical cancer screening recommendations, published in 2024, describe specific-use algorithms for p16/Ki-67 dual-staining cytology as an effective triage test, and also offer insight on how this test can best fit into clinical practice. Join Drs. Warner Huh and Kimberly Levinson as they first establish the rationale for using p16/Ki-67 dual-staining cytology and then break down the most salient algorithms for its use as offered in the recent recommendations.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Paul Llobet, MD

Guest: Holly Llobet, MD

Drs. Paul and Holly Llobet have been traveling the world as locum tenens physicians for over four years now, and their career has taken them to places they never would’ve expected. Tune in to learn more about their adventures in places like Guam and India as well as how locum tenens has impacted both their careers and relationship as husband and wife.

Guest: Jason Busse, PhD

In light of the opioid epidemic, the use of cannabis for therapeutic purposes is becoming of interest. But since there are other alternatives that are often more effective and have better safety profiles, it’s important to understand the evidence and guideline recommendations around these two treatment options. Here to share key considerations for using opioids and cannabis to treat patients living with chronic pain is Dr. Jason Busse, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.

Host: Marianna Fontana, MD

Guest: Ronald Witteles, MD

Struggling to manage ATTR-CM? Our faculty are exploring the key considerations shaping current clinical trial design and how innovations might change our approach to the management of ATTR-CM in the future. They'll also discuss the use of outpatient diuretic intensification as a potential endpoint in trials and the ongoing challenge of defining and measuring “clinically meaningful benefit” for patients with ATTR-CM. Don't miss this opportunity to gain valuable insights and elevate your understanding of ATTR-CM treatment strategies!

Guest: Ripal Patel, MD, MPH

Guest: Trevor Cabrera, MD

Guest: Nick Kusnezov, MD

Guest: Marye Lois McCroskey, MD

Tune in to hear four clinicians from the Locumstory Physician Advisory Board share their experiences working as locum tenens and providing care to patients all over the world. This expert panel features Drs. Ripal Patel, Nicholas Kusnezov, Trevor Cabrera, and Marye Lois McCroskey, who all answer the question: why locum tenens?

Host: Marc P. Bonaca, MD, MPH

This program brings you select scientific abstracts and late-breaking results from the recent American College of Cardiology 2024 Scientific Sessions and the 92nd European Atherosclerosis Society (EAS) Congress. From clinical trials like PIONEER-AF, VOYAGER PAD, SHASTA 2 and MUIR to updates on the new guidelines, faculty experts are here to break down ways to advance cardiovascular care for all.